Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Response Genetics Inc RGDXQ

Response Genetics, Inc. is a life science company. The Company is engaged in the research, development, marketing and sale of pharmacogenomic tests for use in the treatment of cancer. To generate pharmacogenomic information from patient specimens for these tests, the Company uses its own methods for the extraction and analysis of nucleic acids and accessing the genetic information available... see more

Recent & Breaking News (GREY:RGDXQ)

Response Genetics, Inc. Announces First Quarter 2014 Financial Results

GlobeNewswire May 8, 2014

Response Genetics, Inc. to Release First Quarter 2014 Financial Results and Host Conference Call on May 8, 2014

GlobeNewswire May 1, 2014

Response Genetics Enters Next Generation Sequencing Market With Proprietary Panel for Lung Cancer Developed by the Knight Cancer Institute at Oregon Health & Science University

GlobeNewswire April 21, 2014

Response Genetics, Inc. Announces Contracts With Six New Provider Networks

GlobeNewswire April 3, 2014

Response Genetics, Inc. Announces Fourth Quarter and Year-End 2013 Financial Results

GlobeNewswire March 20, 2014

Response Genetics, Inc. to Release Fourth Quarter and Year-End 2013 Financial Results and Host Conference Call on March 20, 2014

GlobeNewswire March 12, 2014

Response Genetics, Inc. to Offer Expanded KRAS Mutation Test to Improve Treatment Decisions for Colorectal Cancer Patients

GlobeNewswire March 10, 2014

Response Genetics Receives Third GSK Milestone Payment

Globe Newswire January 27, 2014

Response Genetics, Inc. Announces Contracts With Two Additional Blue Cross Blue Shield Plans

Globe Newswire December 18, 2013

Response Genetics, Inc. Announces Proposed Underwritten Public Offering

Globe Newswire December 12, 2013

Response Genetics, Inc. Announces Four New Contracts With National PPO Networks

Globe Newswire November 13, 2013

Response Genetics, Inc. Announces Payor Contract With Fortified Provider Network

Globe Newswire October 2, 2013

Response Genetics, Inc. Announces Contract With Three Rivers Provider Network

Globe Newswire September 25, 2013

Response Genetics, Inc. Announces $1.9 Million Registered Direct Offering

Globe Newswire September 20, 2013

InvestorsGuru.com 39 Filtered Mid-Day Market Movers Recap

Investors Guru September 1, 2013

Five Star Equities Issues New Research Reports on AMBA, CIMT, RGDX and TSN

Accesswire August 27, 2013

Response Genetics, Inc. Acquires Proprietary FDA-Cleared and Medicare-Reimbursed Test and All Associated Assets for Difficult to Diagnose Solid Tumors

Globe Newswire August 26, 2013

Response Genetics, Inc. Announces Contract With MultiPlan, Inc.

Globe Newswire August 12, 2013

Response Genetics, Inc. Announces Second Quarter 2013 Financial Results

Globe Newswire August 8, 2013

Response Genetics, Inc. to Release Second Quarter 2013 Financial Results and Host Conference Call on August 8, 2013

Globe Newswire July 31, 2013